Preliminary experiments suggest conolidine may well inhibit specific ion channels, reducing neuronal excitability and limiting suffering alerts. This system is especially appropriate in neuropathic agony, the place irregular signaling results in persistent irritation. Moreover, conolidine seems to affect G protein-coupled receptor (GPCR) pathways i